| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
2,453 |
2,154 |
$287K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
1,443 |
1,251 |
$264K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
4,016 |
3,361 |
$95K |
| 80053 |
Comprehensive metabolic panel |
2,859 |
2,450 |
$73K |
| 36415 |
Collection of venous blood by venipuncture |
6,391 |
5,431 |
$61K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
506 |
481 |
$49K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,028 |
986 |
$47K |
| 86738 |
|
489 |
465 |
$24K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
473 |
419 |
$21K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,647 |
1,559 |
$20K |
| 87631 |
|
151 |
148 |
$18K |
| 87634 |
|
66 |
64 |
$13K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
152 |
152 |
$11K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
127 |
122 |
$10K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
66 |
63 |
$10K |
| 87581 |
|
134 |
131 |
$9K |
| 71045 |
Radiologic examination, chest; single view |
67 |
66 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
77 |
69 |
$4K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
19 |
18 |
$4K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
20 |
19 |
$3K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
24 |
24 |
$2K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
53 |
50 |
$2K |
| 71046 |
Radiologic examination, chest; 2 views |
12 |
12 |
$2K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17 |
15 |
$1K |
| 99307 |
|
82 |
79 |
$911.90 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
47 |
44 |
$719.61 |
| 86140 |
|
17 |
15 |
$580.82 |
| 83605 |
|
26 |
25 |
$552.91 |
| 84145 |
|
12 |
12 |
$472.09 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
33 |
24 |
$452.49 |
| 80061 |
Lipid panel |
12 |
12 |
$444.32 |
| 84443 |
Thyroid stimulating hormone (TSH) |
14 |
13 |
$437.58 |
| 84550 |
|
31 |
24 |
$435.11 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
60 |
53 |
$388.50 |
| 81003 |
|
13 |
13 |
$160.06 |
| 85652 |
|
17 |
15 |
$115.53 |